Recent trends in the development of in vitro 3D kidney models
Source abstract
Abstract
Abstract The kidneys are vital for maintaining bodily homeostasis and are susceptible to various diseases that disrupt their function. Traditionally, research on kidney diseases has relied on animal models and simplistic two-dimensional cell cultures, which do not fully replicate human tissue pathology. To address this, recent advances focus on developing advanced 3D biomimetic in vitro models using human-derived cells. These models mimic healthy and diseased kidney tissues with specificity, replicating key elements like glomerular and tubular structures through tissue engineering. By closely mimicking human physiology, they provide a promising platform for studying renal disorders, drug-induced nephrotoxicity, and evaluating new therapies. However, the challenges include optimizing scalability, reproducibility, and long-term stability to enhance reliability in research and clinical applications. This review highlights the transformative potential of 3D biomimetic in vitro kidney models in advancing biomedical research and clinical applications. By focusing on human-specific cell cultures and tissue engineering techniques, these models aim to overcome the limitations of conventional animal models and simplistic 2D cell cultures. The review discusses in detail the various types of biomimetic kidney models currently under development, their specific applications, and the innovative approaches used to construct them. It also addresses the challenges and limitations associated with these models for their widespread adoption and reliability in research settings.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine · Renal and related cancers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Tanner · 2013
2. Murray · 2025
3. Chronic kidney disease10.1016/S0140-6736(16)32064-5 ↗
4. Acute kidney injury10.1038/s41572-021-00284-z ↗
5. Hypertension in patients with acute kidney injury10.36740/WLek201911201 ↗
6. Acute kidney injury in diabetic patients: a narrative review10.1097/MD.0000000000033888 ↗
7. Drug-induced renal disorders10.12861/jrip.2015.12 ↗
8. Acute kidney injury: a bona fide complication of diabetes10.2337/db20-0604 ↗
9. The impact of chronic kidney disease on global health10.1038/s41581-020-0268-7 ↗
10. Epidemiology of chronic kidney disease: an update 202210.1016/j.kisu.2021.11.003 ↗
11. Glucose-induced reactiveoxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy10.2337/diabetes.55.01.06.db05-0894 ↗
12. Unilateral nephrectomized SHR/NDmcr-cp rat shows a progressive decline of glomerular filtration with tubular interstitial lesions10.33549/physiolres.934969 ↗
13. Kidney-based in vivo model for drug-induced nephrotoxicity testing10.1038/s41598-020-70502-3 ↗
14. Animal models of chronic kidney disease: useful but not perfect10.1093/ndt/gft071 ↗
15. Kidney-based in vitro models for drug-induced toxicity testing10.1007/s00204-019-02598-0 ↗
16. Engineered in vitro disease models10.1146/annurev-pathol-012414-040418 ↗
17. Recent advances in kidney bioengineering10.3389/fped.2021.743301 ↗
18. Function of the nephron and the formation of urine10.1016/j.mpaic.2021.05.004 ↗
19. The glomerular filtration barrier: a structural target for novel kidney therapies10.1038/s41573-021-00242-0 ↗
20. The glomerulus: the sphere of influence10.2215/CJN.09400913 ↗
21. Glomerular filtration barrier assembly: an insight10.14304/SURYA.JPR.V1N4.4 ↗
22. Madrazo-Ibarra · 2020
23. The kidneys, renal function and kidney disease
24. Proximal nephron10.1002/cphy.c110061 ↗
25. Thick ascending limb of the loop of Henle10.2215/CJN.04480413 ↗
26. The distal convoluted tubule10.1002/cphy.c140002 ↗
27. McMahon · 2022
28. Tissue engineering approaches in the design of healthy and pathological in vitro tissue models10.3389/fbioe.2017.00040 ↗
29. 2D and 3D cell cultures–a comparison of different types of cancer cell cultures10.5114/aoms.2016.63743 ↗
30. In vitro micro tissue and organ models for toxicity testing10.1016/B978-0-444-64046-8.00307-4 ↗
31. Cell-based drug testing; this world is not flat10.1016/j.addr.2014.04.001 ↗
32. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance10.18632/oncotarget.9935 ↗
33. Bioengineering strategies for nephrologists: kidney was not built in a day10.1080/14712598.2020.1709439 ↗
34. A composite hydrogel scaffold permits self‐organization and matrix deposition by cocultured human glomerular cells10.1002/adhm.201900698 ↗
35. The effect of electrospun polycaprolactone scaffold morphology on human kidney epithelial cells10.1088/1748-605X/aa8dde ↗
36. Electrospinning fabrication methods to incorporate laminin in polycaprolactone for kidney tissue engineering10.1007/s13770-021-00398-1 ↗
37. Electrospun scaffolds for tissue engineering: a review10.3390/macromol3030031 ↗
38. Cell-electrospinning and its application for tissue engineering10.3390/ijms20246208 ↗
39. Recent advances in bioprinting techniques: approaches, applications and prospects10.1186/s12967-016-1028-0 ↗
40. The use of hydrogels for cell-based treatment of chronic kidney disease10.1042/CS20180434 ↗
41. Mechanics of 3d cell–hydrogel interactions: experiments, models, and mechanisms10.1021/acs.chemrev.1c00046 ↗
42. Microfluidics and hydrogel: a powerful combination10.1016/j.reactfunctpolym.2019.104314 ↗
43. Bioengineered kidney models: methods and functional assessments10.1093/function/zqab026 ↗
44. Overcoming kidney organoid challenges for regenerative medicine10.1038/s41536-020-0093-4 ↗
45. Kidney organoids: accurate models or fortunate accidents10.1101/gad.329573.119 ↗
46. Advancements in kidney organoids and tubuloids to study (dys) function10.1016/j.tcb.2023.09.005 ↗
47. Disease modeling with kidney organoids10.3390/mi13091384 ↗
48. Challenges of organoid research10.1146/annurev-neuro-111020-090812 ↗
49. The “3Ds” of growing kidney organoids: advances in nephron development, disease modeling, and drug screening10.3390/cells12040549 ↗
50. Hydrogel-based cell therapies for kidney regeneration: current trends in biofabrication and in vivo repair10.2174/1381612823666170710155726 ↗
51. A comprehensive review on advancements in tissue engineering and microfluidics toward kidney-on-chip10.1063/5.0087852 ↗
52. Biosynthetic, biomimetic, and self-assembled vascularized organ-on-a-chip systems10.1016/j.biomaterials.2020.120556 ↗
53. Kidney-on-a-chip: untapped opportunities10.1016/j.kint.2018.06.034 ↗
54. Microfluidic bioscaffolds for regenerative engineering10.1016/j.engreg.2021.12.003 ↗
55. 3D bioprinting of cells, tissues and organs10.1038/s41598-020-70086-y ↗
56. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling10.1016/j.addr.2018.06.011 ↗
57. Co-axial printing of convoluted proximal tubule for kidney disease modeling10.1088/1758-5090/ac7895 ↗
58. Electrospinning of nanofibres10.1038/s43586-023-00278-z ↗
59. Cell electrospinning and its application in wound healing: principles, techniques and prospects10.1093/burnst/tkad028 ↗
60. Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management10.3390/pharmaceutics13030357 ↗
61. 3D bioprinting of tissues and organs10.1038/nbt.2958 ↗
62. A critical review of current progress in 3D kidney biomanufacturing: advances, challenges, and recommendations10.1186/s41100-019-0218-7 ↗
63. Bioprinting of kidney in vitro models: cells, biomaterials, and manufacturing techniques10.1042/EBC20200158 ↗
64. Electrospinning and electrospun nanofibers: methods, materials, and applications10.1021/acs.chemrev.8b00593 ↗
65. A concise review on electrospun scaffolds for kidney tissue engineering10.3390/bioengineering9100554 ↗
66. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering10.1089/ten.2005.11.1574 ↗
67. A biomimetic electrospun membrane supports the differentiation and maturation of kidney epithelium from human stem cells10.3390/bioengineering9050188 ↗
68. An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane10.1371/journal.pone.0020802 ↗
69. Fabrication of kidney proximal tubule grafts using biofunctionalized electrospun polymer scaffolds10.1002/mabi.201800412 ↗
70. Renal biology driven macro-and microscale design strategies for creating an artificial proximal tubule using fiber-based technologies10.1021/acsbiomaterials.1c00408 ↗
71. Fabrication and applications of microfluidic devices: a review10.3390/ijms22042011 ↗
72. Microfluidic-based 3D models of renal function for clinically oriented research
73. Organ/body-on-a-chip based on microfluidic technology for drug discovery10.1016/j.dmpk.2017.11.003 ↗
74. A personalized glomerulus chip engineered from stem cell-derived epithelium and vascular endothelium10.3390/mi12080967 ↗
75. Development of a functional glomerulus at the organ level on a chip to mimic hypertensive nephropathy10.1038/srep31771 ↗
76. A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice10.1039/C7LC00134G ↗
77. A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier10.1038/s41467-018-07882-8 ↗
78. A novel microfluidic device to model the human proximal tubule and glomerulus10.1039/C6RA25641D ↗
79. A microfluidic bioreactor with integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cells10.1002/bit.22835 ↗
80. Efficient drug screening and nephrotoxicity assessment on coculture microfluidic kidney chip10.1038/s41598-019-56847-4 ↗
81. Guided tissue organization and disease modeling in a kidney tubule array10.1016/j.biomaterials.2018.07.059 ↗
82. Engineered kidney tubules for modeling patient-specific diseases and drug discovery10.1016/j.ebiom.2018.06.005 ↗
83. Kidney-on-a-chip: mechanical stimulation and sensor integration10.3390/s22186889 ↗
84. Human disease models in drug development10.1038/s44222-023-00063-3 ↗
85. Application of microfluidic chips in the simulation of the urinary system microenvironment10.1016/j.mtbio.2023.100553 ↗
86. Current developments in 3D bioprinting for tissue and organ regeneration–a review10.3389/fmech.2020.589171 ↗
87. A review on four-dimensional bioprinting in pursuit of advanced tissue engineering applications10.1016/j.bprint.2022.e00203 ↗
88. Advances in 3D bioprinting10.1016/j.cjmeam.2022.100011 ↗
89. Bioprinting of 3D convoluted renal proximal tubules on perfusable chips10.1038/srep34845 ↗
90. Scalable fabrication of renal spheroids and nephron-like tubules by bioprinting and controlled self-assembly of epithelial cells10.1088/1758-5090/abe185 ↗
91. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation10.1038/s41563-020-00853-9 ↗
92. Microfluidic bioprinting towards a renal in vitro model10.1016/j.bprint.2020.e00108 ↗
93. Bioinks for 3D bioprinting: an overview10.1039/C7BM00765E ↗
94. Crosslinking strategies for 3D bioprinting of polymeric hydrogels10.1002/smll.202002931 ↗
95. Persuasive factors on the bioink printability and cell viability in the extrusion-based 3D bioprinting for tissue regeneration applications10.1016/j.engreg.2023.03.008 ↗
96. Overview of natural hydrogels for regenerative medicine applications10.1007/s10856-019-6318-7 ↗
97. Engineering hydrogels as extracellular matrix mimics10.2217/nnm.10.12 ↗
98. Design challenges in polymeric scaffolds for tissue engineering10.3389/fbioe.2021.617141 ↗
99. A review of hydrogels, their properties and applications in medicine10.34297/AJBSR.2021.11.001682 ↗
100. A biomimetic gelatin-based platform elicits a pro-differentiation effect on podocytes through mechanotransduction10.1038/s41598-016-0028-x ↗